Hinova Pharmaceuticals’ HP518 gets FDA fast track designation in triple-negative breast cancer

Hinova Pharmaceuticals Inc. (688302.SH), a trailblazer in the biopharmaceutical industry, has achieved a significant milestone with the U.S. Food and Drug Administration (FDA) granting Fast ... Read More